Investor presentation June CEO Lars Marcher
|
|
- Doreen Flowers
- 6 years ago
- Views:
Transcription
1 Investor presentation June 2015 CEO Lars Marcher
2 Agenda AMBU - transformation process Status on business Financials and outlook Q&A Disclaimer Forward-looking statements, especially such relating to future sales and operating profit, are subject to risks and uncertainties. Various factors, many of which are outside Ambu s control, may cause the actual development of the company to differ materially from the expectations contained in this presentation. Factors that might affect such expectations include, among others, changes in healthcare, in the world economy and in exchange rates. 2
3 Ambu at a glance 2,350 employees worldwide Revenue of DKK 1,584m in 2013/14. 99% of Ambu s products are exported Ambu is domiciled in Copenhagen, Denmark Ownership: Three families hold Class A shares. 22% of capital and 60% of voting rights. Listed on NASDAQ OMX Copenhagen with a market cap of ~ DKK 5bn Business areas: Anaesthesia (54%) Ventilation bags, laryngeal masks and face masks for artificial ventilation, breathing bags, circuits as well as visualisation devices Users: Hospitals and ambulance services Patient monitoring & diagnostics (38%) Electrodes for mapping cardiac rhythm and diagnosing diseases in nerves and muscles, and sensors for sleep studies Users: Hospitals, ambulance services and sleep laboratories Emergency Care (8%) Neck collars and manikins for first-aid training Users: Hospitals, ambulance services, aid organisations and the armed forces 1
4 A rich heritage and history 4
5 Ambu the last 5 years - From local to global manufacturing, R&D, IT, RA and sales - Focus on quality - Highly scalable business in place - Growth drivers developed Share price
6 Leading market positions - Complementary product categories stronger sales force ANAESTHESIA Market Position EMS & PMD Market Position Circuits 1 KV in EMS 1 Face masks 1 Cardiology EMS 1 Laryngeal masks 2 Collars 1 Resuscitators 1 Neurophysiology 2 Disposable flexible 1 intubation IOM 2 6
7 Manufacturing worldwide Malaysia, Penang Production of videoscopes, surface electrodes for ECG measurements, neurological surface and needle electrodes China, Xiamen Production of ventilation bags, face masks, laryngeal masks, PEEP valves and suction pumps, LifeKey, neck collars and training manikins USA, Indiana Production of disposable face masks, breathing bags, circuits and laryngeal tubes Eugene Kang, Senior Technician, Penang UK, Warwick Production of hydrogels for electrode monitoring, ECG Surface electrodes for Cardiology, diathermy plates 7
8 Global sales Revenue by geographical region 8
9 Global innovation 9
10 Solid financial development DKKm Sales CAGR of 11%* Sales by Geography /14 North America 44% Europe 44% Rest of world 200 EBIT - CAGR of 11% Sales by Business Area 2013/ % 54% Anaesthesia Patient Monitoring & Diagnostics DKKm Emergency Care * Including acquisitions
11 Share price past 3 years 200,00 180,00 160,00 140,00 120,00 100,00 80,00 60,00 40,00 20,00 0, June May
12 New strategy climbing new heights - Climbing revenues to DKK 2 Billion Revenues (mdkk) Expand visualisation platform with new products Optimise Ambu Classic offering and improve cross-selling New channels & market segments Drive Anaesthesia penetration with combined offering Partnering to adjacent businesses % 9% 9% % 10% 5% 0% -5% -10% -15% -20% -25% -30% 12
13 Improving profitability Operational optimisation: Lowest costs in industry Innovation for premium price products Pricing optimisation Synergy effects and economies of scale From 11.6% to 17-18% EBIT margins within 4 years;
14 Financial results and outlook
15 Strong growth in North America Q2 organic growth 5% 13% 6% Q2 revenue split 8% 43% 49% Europe Growth of 5% Good momentum across major markets Strong sales of new and classic Ambu products North America Growth of 13% Backlog of orders now eliminated New GPO contracts won in Q2 Rest of the world Growth of 6% Negative growth in Latin America due to delayed product registrations Growth in Asia is 32% Growth rates stated in local currency 15
16 Anaesthesia continues outperform market Anaesthesia Growth of 19% Above market growth in all product categories ascope 3 sales up 32% compared to Q1 Q2 organic growth -2% -8% 19% Patient Monitoring & Diagnostics Negative growth of 2% Growth affected by periodic variations of contracts Q2 revenue split 7% Emergency Care Negative growth of 8% Segment is sensitive to project sales 34% 59% Growth rates stated in local currency 16
17 The ascope case Cost A total of 7 studies has compared costs. 6 of them in favour of ascope Availability ascope now available at 1,500 hospitals worldwide Cross-infection risk Increasing international concern regarding drug-resistant infections 17
18 ascope trends in direct markets USA 7% of hospitals buy ascope 67% ascope 3 rebuy rate 2 Europe 1 14% of hospitals buy ascope 78% Australia 26% ascope rebuy rate 2 of hospitals buy ascope % ascope 3 rebuy rate 2 1. Direct markets in Europe: Denmark, Sweden, Finland, UK, Germany, France, Netherlands, Spain, Italy 2. Rebuy rate based on ascope 3 & 3 Slim sales to direct customers in Q2 2014/15
19 Q2: Highest ascope growth yet 32% increase in number of ascopes sold compared to Q1 Year-to-date sales of ascope equals full-year sales last year Q2 average rebuy rate 75% More sales reps and focus on training Increased production capacity in Q1 Q1 Q2 Q3 Q4 Q1 Q2 2013/ /
20 Financial results DKKm Q2 14/15 Q2 13/14 Revenue Gross profit Gross Margin (%) Capacity costs EBIT b.s.i EBIT-margin b.s.i. (%) Financials, net 29-6 Net result DKKm Q2 14/15 Q2 13/14 Cash flow from operations Cash flow from investments Free cash flow 4 26 Organic growth of 9% and 20% in DKK Significant impact from appreciating USD on top-line while neutral on EBIT Scale effect on gross margin from Fx and impact from price and mix Capacity costs impacted by Fx, while underlying run rate is flat Financials impacted by Fx gain Lower cash flow from operations due to increasing inventories and receivables Higher investments due to ascope factory and R&D activities 20
21 Balance sheet DKKm Q2 14/15 Q2 13/14 Total assets 2,371 1,925 Equity Working capital Net interest-bearing debt Gearing (NIBD/EBITDA b.s.i.) Working capital (% of revenue) Investments (% of revenue) 5 3 ROIC (% after tax incl. goodwill) Additional working capital required to support growth Increased investments to support R&D and factory in Malaysia Collections slightly below previous quarter due to seasonality Peak in net interest-bearing debt Gearing at 2.8. Full-year target remains at
22 Full-year 2014/15 outlook Outlook for 2014/15 Local currency Danish kroner 6 May, February, May, February, 2015 Revenue 8-8.5% 7-8% ~19% ~16% EBIT-margin % (fixed rate) % (fixed rate) ~12.0% ~12.5% Free cash flows - - DKK m DKK m Gearing - - ~2.2 ~2.2 22
23 In summary Strong growth case maintained New product introductions generating strong positions Global position continued to strengthen Full-year outlook adjusted for higher growth AMBU well on track to achieve 2017 targets 23
24 Q&A
25 Read more at Contact CEO Lars Marcher, or CFO Michael Højgaard, or
Q1 interim report 2016/17 October 1 December CEO Lars Marcher CFO Michael Højgaard Conference call: February
Q1 interim report 2016/17 October 1 December 31 2016 CEO Lars Marcher CFO Michael Højgaard Conference call: February 1 2017 Agenda Q1 highlights ascope update Financials and outlook Q&A Disclaimer Forward-looking
More informationQ1 interim report 2014/15 October December CEO Lars Marcher CFO Michael Højgaard
Q1 interim report 2014/15 October 1 2014 December 31 2014 CEO Lars Marcher CFO Michael Højgaard Agenda Q1 Highlights Status on business Status on projects Financials Outlook Q&A Disclaimer Forward-looking
More informationResults Q4 2013/14 Guidance FY 2014/15
Results Q4 20 Guidance FY 2014/15 October 1 2013 September 30 2014 CEO Lars Marcher CFO Michael Højgaard Agenda Q4 and FY Highlights Business trends Growth drivers Financials Outlook Q&A Disclaimer Forward-looking
More informationAMBU 2015/16 AHEAD OF TARGETS. Investor update
AMBU 2015/16 AHEAD OF TARGETS Investor update Financial highlights DKKm 2015/16 2014/15 2013/14 2012/13 2011/12 Key figures Revenue 2,084 1,889 1,584 1,383 1,045 EBITDA before special items 458 332 286
More informationINTERIM REPORT Q2 2009/10 By CEO Lars Marcher and CFO Anders Arvai
INTERIM REPORT Q2 2009/10 By CEO Lars Marcher and CFO Anders Arvai AGENDA Developments in Q2 2009/10 Strategy GPS Four follow-up Outlook for 2009/10 HIGHLIGHTS (1) BUSINESS DEVELOPMENT IN Q2 Good Q2. Both
More informationAnnual report 2014/15 October September CEO Lars Marcher CFO Michael Højgaard Webcast: November
Annual report 2014/15 October 1 2014 September 30 2015 CEO Lars Marcher CFO Michael Højgaard Webcast: November 11 2015 Agenda Q4 and FY highlights Overall business status Financials and outlook Q&A Disclaimer
More informationAnnual report 2016/17 October September CEO Lars Marcher CFO Michael Højgaard Webcast: November
Annual report 2016/17 October 1 2016 September 30 2017 CEO Lars Marcher CFO Michael Højgaard Webcast: November 9 2017 Agenda Q4 and FY highlights Visualisation in a new perspective Financials and outlook
More informationInterim report for Q2 2014/15 and for the period 1 October March 2015
Interim report for Q2 and for the period 1 October 2014-31 March 2015 increases revenue to DKK 483m. Organic growth of 9% was recorded in local currencies, and of 20% in Danish kroner. The outlook for
More informationInterim report for Q1 2014/15 (1 October - 31 December)
Interim report for 2014/15 (1 October - 31 December) continues to consolidate its global market position, posting revenue of DKK 388m and organic growth of 13% in Danish kroner, and 9% in local currencies.
More informationInterim report for Q3 2013/14 (1 April - 30 June)
Interim report for (1 April - 30 June) Organic growth in revenue of 8% and gross margin improved to 51.6%. EBIT increased by 41% to DKK 55m. The outlook for the year is maintained, and the estimated growth
More informationInterim report for Q1 2015/16
Interim report for got off to a good start, posting revenue of DKK 462m and organic growth of 11% in local currencies, and 19% in Danish kroner. Earnings increased significantly to DKK 46m. is traditionally
More informationWelcome to the Annual Meeting in Ambu A/S
Welcome to the Annual Meeting in Ambu A/S Agenda 1. Management s review of the company s activities in the past year 2. Presentation of the annual report and the consolidated financial statements for adoption
More informationQ2 interim report 2017/18
Q2 interim report 2017/18 January 1 March 31, 2018 CEO Lars Marcher CFO Michael Højgaard Conference call: May 7 2018 Agenda Q2 highlights Visualisation by 2020 Financials and outlook Q&A Disclaimer Forward-looking
More informationSpring/summer 2017/18. CEO Lars Marcher
Spring/summer 2017/18 CEO Lars Marcher Agenda Q2 highlights Visualisation by 2020 Financials and outlook Q&A Disclaimer Forward-looking statements, especially such relating to future sales and operating
More informationInterim report Q1 2017/18
Interim report 2017/18 has had a good start to the year with organic growth of 14%, an almost 4 percentage point improvement in the EBIT margin to 16.5% and free cash flows of DKK 36m. Our outlook on earnings
More informationInterim report Q3 2016/17
Interim report raises its outlook for the year after a quarter with growth of 16%, an EBIT margin of 21.6% and free cash flows of DKK 99m. In, we again saw a steady increase in growth and a solid increase
More informationInterim report Q1 2018/19
Interim report 2018/19 In, realised organic growth of 15% and a 43% increase in sales of endoscopes to 149,000 units. Gross profit increased by 1.9 percentage points to 59.9%, resulting in an EBIT margin
More informationFocus on clean devices Financial highlights Ambu at a glance
1 Page 4 Page 5 Page 6 Focus on clean devices Financial highlights Ambu at a glance Page 9 Industry Page 10 Business model Page 11 Strategy Page 13 Financial outlook for 2018/19 Page 16 Page 17 Page 18
More informationReport for Q3 2006/07 (1 April - 30 June 2007)
Report for (1 April - 30 June 2007) Ambu saw a high level of activity in, but the decision not to go ahead with heavily discounted sales to a number of large customers in the USA means that, as announced
More informationInterim report for Q2 2017/18 and for the half-year (1 October March 2018)
Interim report for and for the half-year (1 October 2017 31 March 2018) Reporting organic growth in of 15%, is well on the way to realising its Big Five 2020 targets with satisfactory gross margins and
More informationInterim report Q3 2017/18
Interim report reports organic growth of 17% in and raises its outlook for this year s EBIT margin by 1 percentage point. Moreover, the target for sales of endoscopes is increased to 550,000 units. Our
More informationWelcome to Annual General Meeting 2016/ December 2017 Tivoli Hotel & Congress Center
Welcome to Annual General Meeting 2016/17 13 December 2017 Tivoli Hotel & Congress Center Agenda 1. The management s report 2. Annual report and consolidated financial statements 3. Appropriation of profits
More information300 million patients. 100 million patients. Positive impact on more lives. Better health economy. More decisionpower
1 100 million patients Positive impact on more lives Better health economy 300 million patients New application areas with single-use visualisation More decisionpower to patients This is Ambu *Before
More informationdbaccess Global Consumer Conference in Paris
dbaccess Global Consumer Conference in Paris Royal Unibrew A/S By Lars Jensen, CFO 13 June 217 1 Facts about Royal Unibrew Royal Unibrew is the second biggest brewer in the Nordic and Baltic region Revenue
More informationTELECONFERENCE Q FINANCIAL RESULTS. 10:00 CET, 11 August 2015
TELECONFERENCE FINANCIAL RESULTS 10:00 CET, 11 August 2015 1 AGENDA AGENDA Business highlights: Key developments in Market development and sales-out Performance of newly launched products Guidance 2015
More informationTELECONFERENCE Q FINANCIAL RESULTS
TELECONFERENCE FINANCIAL RESULTS 10:00 CET, 13 May 2014 1 AGENDA AGENDA Business highlights: Key developments in Market development and sales-out Performance of newly launched products Guidance 2014 Financial
More informationTELECONFERENCE FY 2014 FINANCIAL RESULTS
TELECONFERENCE FY 2014 FINANCIAL RESULTS 10:00 CET, 17 February 2015 1 DISCLAIMER Certain statements in this presentation constitute forward-looking statements. Forward-looking statements are statements
More informationTELECONFERENCE Q FINANCIAL RESULTS
TELECONFERENCE Q3 2013 FINANCIAL RESULTS 10:00 CET, 12 November 2013 1 AUGUST 2013 INVESTOR PRESENTATION AGENDA AGENDA Business highlights: Key developments in Q3 2013 Market development and sales-out
More informationTELECONFERENCE Q FINANCIAL RESULTS. 10:00 CET, 10 November 2015
TELECONFERENCE FINANCIAL RESULTS 10:00 CET, 10 November 2015 1 AGENDA AGENDA Business highlights: Key developments in Market development and sales-out Guidance 2015 Financial review for Recap and Q&A 2
More informationTELECONFERENCE Q FINANCIAL RESULTS
TELECONFERENCE FINANCIAL RESULTS 10:00 CET, 11 November 2014 1 12 AUGUST 2014 AGENDA AGENDA Business highlights: Key developments in Market development and sales-out Performance of newly launched products
More information2015 Annual Report. Investor teleconference 10 February 2016, a.m. CET. Presentation available at investor.dsv.com
2015 Annual Report Investor teleconference 10 February 2016, 11.00 a.m. CET Presentation available at investor.dsv.com Forward-looking statements This presentation contains forward-looking statements.
More informationDanske Bank Markets Copenhagen Winter Seminar
Danske Bank Markets Copenhagen Winter Seminar Royal Unibrew A/S By CEO Hans Savonije and CFO Lars Jensen 11 December 217 1 Performance improvements in line with expectations Overall market positions maintained
More informationTELECONFERENCE PRESENTATION Q3 2012
TELECONFERENCE PRESENTATION 6 November 2012 1 AGENDA AGENDA Important events in Financial highlights Q&A 2 DISCLAIMER Certain statements in this presentation constitute forward-looking statements. Forward-looking
More informationCOMPANY PRESENTATION. Danske Bank Markets Copenhagen Winter Seminar 2016
COMPANY PRESENTATION Danske Bank Markets Copenhagen Winter Seminar 2016 THE GROUP IN SHORT IC GROUP A Danish listed apparel and fashion company operating and developing brands in the Premium segment Revenue
More informationdbaccess Global Consumer Conference June 2018, Paris Royal Unibrew A/S Lars Jensen, CFO
dbaccess Global Consumer Conference June 218, Paris Royal Unibrew A/S Lars Jensen, CFO Royal Unibrew in brief 2 A Leading Regional Beverage Group Royal Unibrew Core markets Niche markets Associated companies,
More informationRoyal Unibrew A/S. by Henrik Brandt, President & CEO 21 May 2015 Nordic Market Day 2015, New York
Royal Unibrew A/S by Henrik Brandt, President & CEO 21 May 2015 Nordic Market Day 2015, New York 1 ROYAL UNIBREW NORDIC MARKET DAY 2015 NEW YORK 21 MAY 2015 Royal Unibrew s goal is to be an efficient regional
More informationSEB Nordic Seminar By Lars Jensen, CFO 10 January 2017
SEB Nordic Seminar 2017 By Lars Jensen, CFO 10 January 2017 1 ROYAL UNIBREW SEB NORDIC SEMINAR 2017 10 JANUARY 2017 A Leading Regional Beverage Group Royal Unibrew Core markets Full range of beverages,
More informationRoyal Unibrew A/S. by Lars Jensen, CFO 24 May Norwegian Clients Reversed Roadshow, Nordea
Royal Unibrew A/S by Lars Jensen, CFO 24 May 216 - Norwegian Clients Reversed Roadshow, Nordea 1 ROYAL UNIBREW NORDEA - NORWEGIAN CLIENTS REVERSED ROADSHOW 24 MAY 216 Performance improvement - in line
More informationRoyal Unibrew A/S. By Lars Jensen, CFO. Bryan, Garnier & Co 2nd European Consumer Conference 29 November 2016
Royal Unibrew A/S By Lars Jensen, CFO Bryan, Garnier & Co 2nd European Consumer Conference 29 November 216 1 ROYAL UNIBREW INVESTOR PRESENTATION BRYAN, GARNIER & CO 29 NOVEMBER 216 Performance as expected
More informationInterim Financial Statement, Q1 2006/07 (1 October December 2006)
Stock Exchange Announcement no. 1/2007 8 February, 2007 Interim Financial Statement, Q1 2006/07 (1 October 2006-31 December 2006) "We are pleased with Coloplast s performance," says Sten Scheibye, President
More informationTELECONFERENCE Q FINANCIAL RESULTS
TELECONFERENCE FINANCIAL RESULTS 10:00 CET, 12 August 2014 1 AGENDA AGENDA Business highlights: Key developments in Market development and sales-out Performance of newly launched products Guidance 2014
More informationQ results and FY outlook. Webcast 15 August 2018
Q2 2018 results and FY outlook Webcast 15 August 2018 Today s agenda Q2 2018 Highlights, markets, financials Update on business priorities Succeed in North America Complete tablet portfolio Digital engagement
More informationRoyal Unibrew A/S. by Lars Jensen, CFO 8 June 2016 Handelsbanken - Nordic Mid/Small Cap Seminar 2016, Stockholm
Royal Unibrew A/S by Lars Jensen, CFO 8 June 2016 Handelsbanken - Nordic Mid/Small Cap Seminar 2016, Stockholm 1 ROYAL UNIBREW HANDELSBANKEN NORDIC MID/SMALL CAP SEMINAR 2016 - STOCKHOLM JUNE 2016 Facts
More informationRoyal Unibrew A/S. by Henrik Brandt, President & CEO May 2016 Nordic Market Day 2016
Royal Unibrew A/S by Henrik Brandt, President & CEO 18-19 May 2016 Nordic Market Day 2016 1 ROYAL UNIBREW NORDIC MARKET DAY BOSTON AND NEW YORK MAY 2016 Facts about Royal Unibrew Royal Unibrew is the second
More informationThird consecutive profitable quarter with continued strong growth
Interim report for the period 1 January 30 September 2015 Announcement No. 10/2015 To NASDAQ Copenhagen Exiqon A/S Skelstedet 16 2950 Vedbæk Denmark 26 October 2015 Phone: +45 4566 0888 Fax: +45 4566 1888
More informationBryan, Garnier & Co. 4 th Consumer, Brands & Retail Conference 25 September 2018
Bryan, Garnier & Co. 4 th Consumer, Brands & Retail Conference 25 September 218 Royal Unibrew A/S Hans Savonije, President & CEO 1 Royal Unibrew in brief 2 A Leading Regional Beverage Group Royal Unibrew
More informationTELECONFERENCE PRESENTATION Q1 2012
TELECONFERENCE PRESENTATION Q1 2012 8 May 2012 1 AGENDA AGENDA Important events in Q1 2012 Stock balancing campaign Realigned price architecture and product range Financial highlights Q&A 2 DISCLAIMER
More informationTELECONFERENCE PRESENTATION Q2 2012
TELECONFERENCE PRESENTATION Q2 2012 7 August 2012 1 AGENDA AGENDA Important events in Q2 2012 Financial highlights Q&A 2 DISCLAIMER Certain statements in this presentation constitute forward-looking statements.
More informationPresentation of Annual Report Klaus Holse, CEO, SimCorp A/S Thomas Johansen, CFO, SimCorp A/S
Presentation of Annual Report 2014 Klaus Holse, CEO, SimCorp A/S Thomas Johansen, CFO, SimCorp A/S Disclaimer This presentation contains certain forward-looking statements and expectations in respect of
More informationTELECONFERENCE Q May 2015
TELECONFERENCE Q1 2015 6 May 2015 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions,
More informationRoyal Unibrew A/S. by Henrik Brandt, President & CEO 15 June 2016 dbaccess Global Consumer Conference, Paris
Royal Unibrew A/S by Henrik Brandt, President & CEO 15 June 216 dbaccess Global Consumer Conference, Paris 1 ROYAL UNIBREW dbaccess GLOBAL CONSUMER CONFERENCE - PARIS JUNE 216 Facts about Royal Unibrew
More informationREMUNERATION REPORT. Remuneration report for Ambu A/S for 2017/18
REMUNERATION REPORT Remuneration report for Ambu A/S for 2017/18 This remuneration report is presented in accordance with the guidelines laid down in the Shareholders Rights Directive (Directive (EU) 2017/1132
More informationSecond quarter Vestas Wind Systems A/S. Copenhagen, 17 August Classification: Public
Second quarter Vestas Wind Systems A/S Copenhagen, 17 August Classification: Public Disclaimer and cautionary statement This document contains forward-looking statements concerning Vestas financial condition,
More informationFull year Vestas Wind Systems A/S. Copenhagen, 7 February Classification: Public
Full year Vestas Wind Systems A/S Copenhagen, 7 February 2018 Classification: Public Disclaimer and cautionary statement This document contains forward-looking statements concerning Vestas financial condition,
More informationInvestor Presentation Q Results. 8 November 2017
Investor Presentation Q3 2017 Results 8 November 2017 Forward-looking statements This presentation contains forward-looking statements, including, but not limited to, the statements and expectations contained
More informationFY MARCH 2011 TELECONFERENCE PRESENTATION
FY 2010 TELECONFERENCE PRESENTATION 15 MARCH 2011 1 4 APRIL 2011 DISCLAIMER This presentation contains forward-looking statements that reflect PANDORA s expectations with respect to certain future events
More informationFIRST QUARTER 2018 RESULTS
FIRST QUARTER 2018 RESULTS Conference call 1 May 2018, 11.00 am CET Presentation available at investor.dsv.com Forward-looking statements This presentation contains forward-looking statements. Such statements
More informationQ Investor Presentation Analyst conference call 30 April 2015, 2.00 p.m. CET
Investor Presentation Analyst conference call 30 April, 2.00 p.m. CET Presentation available at www.dsv.com Forward-looking statements This presentation contains forward-looking statements. Such statements
More informationConsolidated Financial Highlights for FY2014 (From April 1, 2014 to March 31, 2015)
Consolidated Financial Highlights for FY2014 (From April 1, 2014 to March 31, 2015) 1. Consolidated Financial Results for FY2014 2. Forecast for FY2015 3. Revision of four-year mid-term business plan,
More informationTELECONFERENCE Q FINANCIAL RESULTS 10:00 CET, 10 MAY 2016
TELECONFERENCE 2016 FINANCIAL RESULTS 10:00 CET, 10 MAY 2016 AGENDA FINANCIAL HIGHLIGHTS 2016 FINANCIAL EXPECTATIONS 2016 FINANCIAL REVIEW 2016 SUMMARY 2 DISCLAIMER Certain statements in this presentation
More informationExiqon A/S (NASDAQ OMX Copenhagen: EXQ ) today announced results for the first three months of 2015:
Interim report for the quarter 1 January 31 March 2015 Announcement No. 5/2015 To NASDAQ OMX Copenhagen A/S 7 May 2015 Exiqon A/S Skelstedet 16 2950 Vedbæk Denmark CVR nr. 18 98 44 31 Phone: +45 4566 0888
More informationA N N U A L R E P O R T / JULY
ANNUAL REPORT 2016/17 12 JULY 2017 DISCLAIMER This presentation does not constitute or form part of and should not be construed as an offer to sell or issue or the solicitation of an offer to buy or acquire
More informationSchouw & Co. Full Year 2017
Schouw & Co. Full Year 2017 Investor presentation MARCH 2018 CEO JENS BJERG SØRENSEN IR KASPER OKKELS 2017 Annual Report 09.03.2018 2 Schouw & Co. value proposition 1 Diversified portfolio 2 3 Leading
More informationInterim report Q3 2014
Interim report Q3 2014 Contents Management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q3 2014 7 Outlook 8 Risk factors 9 Management statement 20 Hartmann at a glance Interim
More informationHUGO BOSS First Nine Months Results 2011
HUGO BOSS First Nine Months Results 2011 Mark Langer (CFO) November 2, 2011 Conference Call, First Nine Months Results 2011 HUGO BOSS November 2, 2011 2 / 30 AGENDA OPERATIONAL HIGHLIGHTS FIRST NINE MONTHS
More informationSecond quarter Vestas Wind Systems A/S. Copenhagen, 18 August Classification: Public
Second quarter Vestas Wind Systems A/S Copenhagen, 18 August Disclaimer and cautionary statement This presentation contains forward-looking statements concerning Vestas' financial condition, results of
More informationInterim report Q2 2017
Interim report Q2 2017 MANAGEMENT REPORT FINANCIAL STATEMENTS Contents Management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q2 2017 8 Outlook 9 Risk Financial statements
More informationInterim report Q1 2012
Interim report Q1 2012 Contents management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q1 2012 8 Outlook 9 Risk factors 10 Management statement Interim financial statements
More informationCarlsberg A/S. Interim results H1 2015
Carlsberg A/S Interim results H1 2015 Agenda Group highlights Financial results & outlook Operational performance Appendix H1 Group highlights Strong market share improvement in the majority of markets
More informationSolar Equity Story Our three value drivers are growth, EBITA margin and net working capital
Solar Equity Story Our three value drivers are growth, EBITA margin and net working capital Investor presentation Agenda Agenda 1. The results we achieved in Q3 2016 2. Capital structure 3. Outlook 2016
More informationAnnual Report 1 January 31 December 2017
Annual Report 1 January 31 December 217 7 March 217 Results in high end of the outlook guidance Best result ever in spite of poor summer weather Net revenue DKK 6.4bn (DKK 6.3bn) EBIT DKK 1.69m (DKK 1.1)
More informationRelease no Report on the first 9 months of 2014 To NASDAQ Copenhagen A/S
Page 1/11 20 November 2014 for Today the Board of has discussed and approved the following report on the first 9 months of 2014. Highlights Sales in the first 9 months of 2014 at actual exchange rates
More informationHUGO BOSS First Half Year Results 2014
HUGO BOSS First Half Year Results 2014 Claus-Dietrich Lahrs (CEO), Mark Langer (CFO) Metzingen, July 31, 2014 Conference Call, First Half Year Results 2014 HUGO BOSS July 31, 2014 2 / 42 Agenda Half Year
More informationInterim report Q1 2017
Interim report Q1 2017 MANAGEMENT REPORT FINANCIAL STATEMENTS Contents Management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q1 2017 8 Outlook 9 Risk Financial statements
More informationQ4 Report Johan Molin President & CEO
Q4 Report 2010 Johan Molin President & CEO 1 Financial highlights Q4 2010 Strong ending of the year Strong growth in Global Technologies, APAC and South America Americas in solid growth while EMEA remained
More informationThird quarter Vestas Wind Systems A/S. Copenhagen, 9 November Classification: Public
Third quarter Vestas Wind Systems A/S Copenhagen, 9 November Classification: Public Disclaimer and cautionary statement This document contains forward-looking statements concerning Vestas financial condition,
More informationFULL-YEAR RESULTS 2009
FULL-YEAR RESULTS 2009 Presentation by: President & CEO Niels Henrik Jensen Group CFO Michael Østerlund Madsen 25 February 2010 25 February 2010 1 AGENDA EAC Group Hyperinflation Highlights 2009 Segments
More informationFULL YEAR 2018 Vestas Wind Systems A/S
FULL YEAR Vestas Wind Systems A/S Copenhagen, 7 February 2019 DISCLAIMER AND CAUTIONARY STATEMENT This document contains forward-looking statements concerning Vestas financial condition, results of operations
More informationColoplast Earnings Conference Call FY 2017/18 1 November 2018
Coloplast Earnings Conference Call FY 2017/18 1 November 2018 Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance,
More informationInterim report Q3 2017
Interim report Q3 2017 MANAGEMENT REPORT FINANCIAL STATEMENTS Contents Management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q3 2017 8 Outlook 9 Risk Financial statements
More informationConsolidated Financial Highlights for FY2012 (From April 1, 2012 to March 31, 2013)
Consolidated Financial Highlights for FY2012 (From April 1, 2012 to March 31, 2013) 1. Consolidated Financial Results for FY2012 & Forecast for FY2013 2. A four-year business plan Strong Growth 2017 May
More information1 st Quarter, 2014 Danfoss delivers strong first quarter
1 st Quarter, 2014 Danfoss delivers strong first quarter www.danfoss.com www.danfoss.com Danfoss at a glance Danfoss is a world-leading supplier of technologies that meet the growing need for food supply,
More informationFinansanalytikerforeningens Virksomhedsdag 7. juni Jens H. Lund, CFO
Finansanalytikerforeningens Virksomhedsdag 7. juni 2012 Jens H. Lund, CFO Agenda Introduction to DSV High level SWOT analysis Cash flow highlights Net working capital Investing activities Capital structure
More informationInterim Management Statement
Interim Management Statement Covering the period year-to-date 6th November 2018 Our vision is to make a lifechanging difference to people living with hearing loss 2 Key take-aways Key take-aways year-to-date
More informationNASDAQ Copenhagen A/S Nikolaj Plads 6 DK-1007 Copenhagen K
NASDAQ Copenhagen A/S Nikolaj Plads 6 DK-1007 Copenhagen K Announcement no. 26/ 2018 23 April 2018 Company reg. (CVR) no. 15701315 Interim report First quarter of 2018 Summary: SP Group generated profit
More informationCarlsberg A/S. H interim results
Carlsberg A/S H1 2016 interim results Agenda H1 highlights Financial results Region performance Appendix Good H1 performance +140bp Organic GPaL margin improvement -1% +8% Organic decline in pro rata volumes
More informationFinancial results. Full year ended 31 December 2012
Financial results Full year ended 31 December 2012 Agenda Operational performance Financial results Outlook 2013 Appendix Full year result ended 31 December 2012 2 Strong market share performance across
More informationFull year Vestas Wind Systems A/S. Copenhagen, 8 February Classification: Public
Full year Vestas Wind Systems A/S Copenhagen, 8 February 2017 Disclaimer and cautionary statement This document contains forward-looking statements concerning Vestas financial condition, results of operations
More informationRoyal Unibrew A/S Danske Bank Markets Copenhagen Winter Seminar
Royal Unibrew A/S Danske Bank Markets Copenhagen Winter Seminar by Henrik Brandt, President & CEO 5 December 2013 Royal Unibrew s goal is to be an efficient regional beverage player Focus on: Markets and
More informationINTERIM FINANCIAL REPORT H Company Announcement no. 704
INTERIM FINANCIAL REPORT H1 2018 Company Announcement no. 704 1 August 2018 Selected financial and operating data for the period 1 January - 30 June 2018 (DKKm) Q2 2018 Q2 2017 YTD 2018 YTD 2017 Net revenue
More informationTELECONFERENCE Q3 2017
AGENDA BUSINESS HIGHLIGHTS FINANCIAL REVIEW QUESTIONS AND ANSWERS 2 DISCLAIMER Certain statements in this presentation constitute forward-looking statements. Forward-looking statements are statements (other
More informationPHOTOCURE ASA RESULTS FOR FIRST QUARTER MAY Kjetil Hestdal, MD, President & CEO Erik Dahl, CFO
PHOTOCURE ASA RESULTS FOR FIRST QUARTER 2018 23 MAY 2018 Kjetil Hestdal, MD, President & CEO Erik Dahl, CFO DISCLAIMER The information included in this Presentation contains certain forward-looking statements
More informationInterim report Q2 2018
Interim report Q2 2018 MANAGEMENT REPORT FINANCIAL STATEMENTS Contents Management report 3 Highlights 4 Key figures and financial ratios 5 Developments in Q2 2018 8 Outlook 9 Risk Financial statements
More informationFinancial Information
Accelerating & profit in H1: Revenue up +4% reported, Adj. EBITA +8%, Net Income +18%, FCF +15% H1 revenue of 12.2bn, +2.7% organic, +4.1% outside Infrastructure H1 adj. EBITA margin up 60bps 1 org., to
More informationTieto Q4/2011. Lasse Heinonen CFO Reeta Kaukiainen VP, Communications & IR. eto Corporation 2012 Tie
Tieto Q4/2011 Kimmo Alkio President and CEO Lasse Heinonen CFO Reeta Kaukiainen VP, Communications & IR eto Corporation 2012 Tie Summary Financial performance as expected solid order intake A number of
More informationSchouw & Co. first half of 2016
Schouw & Co. first half of Investor presentation AUGUST The best H1 in Schouw & Co. s history Schouw & Co. H1 11.08. 2 Revenue DKK 6.1bn Growth 4.4% // H1: 5.9bn Organic decline from lower volume in BioMar
More informationH1/2018 Results u-blox Holding AG
H1/2018 Results August 24, 2018 Thomas Seiler, CEO Roland Jud, CFO Disclaimer This presentation contains certain forward-looking statements. Such forward-looking statements reflect the current views of
More informationInvestors Conference Commerzbank Sector Conference
Investors Conference Commerzbank Sector Conference August 30, 2017, Frankfurt Clear focus. Sharpened profile. Draft, version 4, as of 3/8/2016, 11:20 a.m. Disclaimer Note: This presentation contains statements
More informationMedia and Financial Analysts Meeting 2013 Carlo Gavazzi Holding AG
Media and Financial Analysts Meeting 2013 Carlo Gavazzi Holding AG Media and Financial Analysts Meeting 2013 June 27, 2013 Media and Financial Analysts Meeting 2013 AGENDA FOR TODAY WELCOME & INTRODUCTION
More informationNet interest-bearing debt at 30 September 2016 was DKK million (30 September 2015: DKK 476 million).
H+H International A/S Interim financial report Company Announcement No. 343, 2016 H+H International A/S Dampfærgevej 3, 3rd Floor 2100 Copenhagen Ø Denmark Tel. +45 35 27 02 00 info@hplush.com www.hplush.com
More information